Brenntag stock last at EUR 60.86 on October 6, 2026

Brenntag stock was last quoted at EUR 60.86 on October 6, 2026, versus a prior close of EUR 59.34. The company recently announced a global biopharma partnership and a bond placement.

Brenntag SE’s BNR.DE quote was last at EUR 60.86 on October 6, 2026, at 5:35 p.m. CEST. The quote was EUR 1.52, or 2.56 percent, above the previous close of EUR 59.34.

Global biopharma distribution partnership

On September 29, 2026, Brenntag Pharma and dsm-firmenich announced a global distribution agreement and long-term strategic partnership for high-purity, GMP-grade vitamins used in cell culture media and biologics manufacturing. The agreement grants Brenntag exclusive distribution rights across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific. The offering will operate under the BYPHAR powered by Biond brand, according to Brenntag.

Bond placement completed

Brenntag said on September 14, 2026, that Brenntag Finance B.V. had placed a EUR 500 million bond with a seven-year maturity and a 4.25 percent coupon. The issue price was 99.626 percent, and the bond was listed on the Euro MTF Market of the Luxembourg Stock Exchange. The company said proceeds would be used for general corporate purposes, according to Brenntag.